Phase I Trial of Tipifarnib (R115777) Concurrent With Radiotherapy in Patients with Glioblastoma Multiforme-Reference-Cited by-同舟云学术

Phase I Trial of Tipifarnib (R115777) Concurrent With Radiotherapy in Patients with Glioblastoma Multiforme

Published:2007-08 Issue:5 Volume:68 Page:1396-1401
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Cohen-Jonathan Moyal Elizabeth,Laprie Anne,Delannes Martine,Poublanc Muriel,Catalaa Isabelle,Dalenc Florence,Berchery Delphine,Sabatier Jean,Bousquet Philippe,De Porre Peter,Alaux Béatrice,Toulas Christine

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference48 articles.

1. Brain tumors;DeAngelis;N Engl J Med,2001

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial;Mirimanoff;J Clin Oncol,2006

4. Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation;Delmas;Int J Cancer,2002

5. The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft;Delmas;Clin Cancer Res,2003

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Oncology in Glioblastoma (GBM);Advanced Imaging and Therapy in Neuro-Oncology;2024

2. The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells;Science Advances;2023-11-03

3. The STEMRI trial: magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma-initiating cells;2023-01-19

4. Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives;Clinical and Translational Radiation Oncology;2023-01

5. The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review;Strahlentherapie und Onkologie;2022-05-03